1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
بواسطة Ma, Jun, Tan, Sze Huey, Yin, Daniel Xing Cheng, Tran, Nguyen Tuan Anh, San Tan, Gek, Lai, Gillianne Geet Yi, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Rajasekaran, Tanujaa, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel Shao-Weng, Lim, Darren Wan-Teck, Ng, Quan Sing, Tan, Wan Ling
منشور في 2024
احصل على النص الكاملمنشور في 2024
مقال
20
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
بواسطة Lai, Gillianne GY, Yeo, Jia Chi, Jain, Amit, Zhou, Siqin, Pang, Mengyuan, Alvarez, Jacob JS, Sim, Ngak Leng, Tan, Aaron C, Suteja, Lisda, Lim, Tze Wei, Guo, Yu Amanda, Shen, Meixin, Saw, Stephanie PL, Rohatgi, Neha, Yeong, Joe PS, Takano, Angela, Lim, Kiat Hon, Gogna, Apoorva, Too, Chow Wei, Da Zhuang, Kun, Tan, Wan Ling, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Wang, Lanying, Toh, Chee Keong, Lim, Wan-Teck, Tam, Wai Leong, Tan, Sze Huey, Skanderup, Anders MJ, Tan, Eng-Huat, Tan, Daniel SW
منشور في 2024
احصل على النص الكاملمنشور في 2024
مقال